---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-024304"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:39:14.121540+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q2 EPS $0.52 +44%, FY guidance raised; dividend $0.16

## Summary
- Sales $55.8M +11% (+12% organic); EPS $0.52 +44% vs Q2 2023.
- Gross margin 68.9% (+490 bps); operating income $14.4M +52%.
- Allografts +30%, bovine patches +12%, carotid shunts +22% led growth.
- Q3 guidance: sales $52.7-54.7M, EPS $0.42-0.46; FY guidance raised to sales $218.8M, EPS $1.82-1.91.
- Quarterly dividend $0.16/share payable Aug 29, record Aug 15.

## SEC filing metadata
- accession: 0001437749-24-024304
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774924024304/0001437749-24-024304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774924024304/lmat20240801_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-024304
- JSON: https://secwatch.observer/filing/0001437749-24-024304.json
- Plain text: https://secwatch.observer/filing/0001437749-24-024304.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.